Alaunos Therapeutics's total assets for Q2 2026 were $1.52M, a decrease of -19.49% from the previous quarter. DE:WEK0 total liabilities were $864.00K for the fiscal quarter, a 45.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.